Indian biotech firm Panacea Biotec Ltd has said it would partner with US-based Refana Inc to make a potential vaccine for Covid-19.
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year
The country is confronting increasingly volatile weather patterns with consequences for agriculture, infrastructure, public health and economic planning.
0
